FluoroPharma Medical, Inc. FluoroPharma Medical, Inc.

FluoroPharma Medical, Inc.

FPMI

Rank in Stocks #34558
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the... FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$6.81K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade FluoroPharma Medical, Inc. (FPMI)

Category

Healthcare
EPS for FluoroPharma Medical, Inc. (FPMI)
EPS as of December 2016 TTM: $-0.06
According to FluoroPharma Medical, Inc.'s latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2016 the company had an EPS of $-0.06, an increase over its 2015 EPS of $-0.11.
EPS history for FluoroPharma Medical, Inc. from 2007 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.06 5.50%
2016 $-0.06 -44.45%
2015 $-0.11 54,900.00%
2014 0.00 -33.33%
2013 0.00 -80.00%
2008 0.00 -78.26%
2007 $-0.01 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 1,306.00%
US
$15.66 -24,839.34%
US
$-7.07 11,069.04%
US
$-5.29 8,257.03%
AU
$12.73 -20,214.06%
BE

Questions about FluoroPharma Medical, Inc.'s earnings per share (EPS)

What is FluoroPharma Medical, Inc.'s earnings per share (EPS)?

FluoroPharma Medical, Inc.'s earnings per share (EPS) over the last twelve months is $-0.06, as of Dec 2016.

What was FluoroPharma Medical, Inc.'s earnings per share (EPS) in 2016?

In 2016, FluoroPharma Medical, Inc.'s earnings per share (EPS) was $-0.06, compared with $-0.11 in 2015.

How has FluoroPharma Medical, Inc.'s earnings per share (EPS) changed since 2013?

From 2013 to 2016, FluoroPharma Medical, Inc.'s earnings per share (EPS) was highest in 2014 (0.00) and lowest in 2015 ($-0.11).

How does FluoroPharma Medical, Inc.'s earnings per share (EPS) compare with similar companies?

FluoroPharma Medical, Inc.'s earnings per share (EPS) ($-0.06) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.